Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes

Overview of attention for article published in New England Journal of Medicine, December 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 18 news outlets
blogs: 4 blogs
twitter: 168 X users
patent: 5 patents
facebook: 4 Facebook pages

googleplus: 1 Google+ user
reddit: 4 Redditors
video: 1 YouTube creator
guideline: 2 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 417 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 4 posts from 4 blogs.

Primecuts – This Week In The Journals

Clinical Correlations, 08 Dec 2016

By Robert Freilich…

Richard Lehman’s journal review—5 December 2016

Latest BMJ blogs, 05 Dec 2016

NEJM 1 Dec 2016 Vol 375Can genes prove how drugs work? Medicine is the application of neat science to a messy world. We love…

Cardioprotective Effect of PCSK9 Inhibitors Should Outweigh Potential Harm of Diabetes Risk

Medical Research News and Interviews: MedicalResearch.com, 01 Dec 2016

MedicalResearch.com Interview with: Brian A. Ference, M.D Division of Cardiovascular Medicine Wayne State University School of…

Genetic Studies Offer Hint Of Clinical Benefits-And Risks- of PCSK9 Inhibitors

CardioBrief, 30 Nov 2016

–Both cardiovascular benefits and increase in diabetes seem likely. There is no more eagerly awaited question in cardiovascular…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.